Cybin’s Breakthrough Therapy for Major Depressive Disorder: A Game-Changer in Mental Health
Cybin, a neuropsychiatry company, recently held a successful meeting with the FDA regarding its Type B Breakthrough Therapy for...
NorthStar and Convergent Expand Collaboration on Conv01-α
NorthStar Medical Radioisotopes and Convergent Therapeutics have inked a contract for manufacturing services, collaborating on CONV01-α, targeted radiotherapy for...
Innovative AI in Trials: Reducing Costs and Enhancing Privacy
In this insightful interview, I spoke with Gen Li, CEO of Phesi, a pioneering company focusing on AI in...
Report Predicts $11.9B Surge in eClinical Solutions Market Driven by Clinical Trial and EHR Adoption
The global market for eClinical solutions, which streamline clinical trials, is projected to expand rapidly, reaching $21.9 billion by...
Alzamend Neuro Partners with MGH for Phase 2 MDD Study
Alzamend Neuro partners with Massachusetts General Hospital, a renowned Harvard Medical School research facility, to conduct a groundbreaking Phase...
Summit Therapeutics HARMONI-2: A Ivonescimab Achieves Clinically Significant Benefits in NSCLC
Summit Therapeutics‘ investigational bispecific antibody, Ivonescimab, has achieved clinically significant benefits in a Phase III trial (HARMONi-2) compared to...
Pfizer Announces Remarkable Results of Abrysvo® for RSV in Immunocompromised Adults: A Transformative Breakthrough
Pfizer has reported positive results from a clinical trial evaluating its vaccine, ABRYSVO, in immunocompromised adults at risk of...
Blue Earth Therapeutics and Seibersdorf Expand Horizons
Blue Earth Therapeutics Expands Manufacturing Collaboration with Seibersdorf Labor Blue Earth Therapeutics, a subsidiary of Bracco, has expanded its...
What Does The Future Hold for RBQM in Clinical Trials?
In this interview, I speak with Duncan Hall, CEO of Tritrials, about the importance of Risk-Based Quality Management (RBQM)...
Advancing Drug Development: FDA’s Take on In Silico Trials
The Clinical Trial Transformation Initiative (CTTI) and the FDA hosted a workshop on Artificial Intelligence in Drug & Biological...